|
US20030109476A1
(en)
*
|
2001-08-07 |
2003-06-12 |
Kmiec Eric B. |
Compositions and methods for the prevention and treatment of Huntington's disease
|
|
US20040096880A1
(en)
*
|
2001-08-07 |
2004-05-20 |
Kmiec Eric B. |
Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
|
|
CA2515484C
(en)
|
2003-02-11 |
2011-09-20 |
Antisense Therapeutics Ltd |
Modulation of insulin like growth factor i receptor expression
|
|
JP2007523895A
(ja)
*
|
2004-01-23 |
2007-08-23 |
オクラホマ メディカル リサーチ ファウンデーション |
過剰な免疫グロブリン産生の治療としてのＢｒｉｇｈｔ機能の阻害方法
|
|
US7776312B2
(en)
*
|
2004-08-13 |
2010-08-17 |
Healthpartners Research Foundation |
Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
|
|
US9216161B2
(en)
|
2004-08-13 |
2015-12-22 |
Healthpartners Research Foundation |
Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity
|
|
US7618615B2
(en)
|
2004-08-13 |
2009-11-17 |
Healthpartners Research Foundation |
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
|
|
AU2005302554A1
(en)
*
|
2004-10-28 |
2006-05-11 |
Idexx Laboratories, Inc. |
Compositions for controlled delivery of pharmaceutically active compounds
|
|
WO2006074177A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Mary Kay Inc. |
Alcohol-free microemulsion composition
|
|
AU2006247215B2
(en)
*
|
2005-05-18 |
2012-09-13 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for real-time nucleic acid analysis in live cells
|
|
WO2007025249A2
(en)
*
|
2005-08-26 |
2007-03-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treatment of headaches by administration of oxytocin
|
|
US8114440B2
(en)
*
|
2005-11-16 |
2012-02-14 |
Idexx Laboratories Inc. |
Pharmaceutical compositions for the administration of aptamers
|
|
US7754679B2
(en)
*
|
2005-11-16 |
2010-07-13 |
Idexx Laboratories, Inc. |
Pharmaceutical compositions for the administration of aptamers
|
|
EP1948199B1
(en)
*
|
2005-11-16 |
2015-08-12 |
IDEXX Laboratories Inc |
Pharmaceutical compositions for the administration of aptamers
|
|
US20080261893A1
(en)
*
|
2006-02-24 |
2008-10-23 |
Denise Barbut |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
GB0605337D0
(en)
*
|
2006-03-17 |
2006-04-26 |
Genomica Sau |
Treatment of CNS conditions
|
|
WO2007127163A2
(en)
|
2006-04-24 |
2007-11-08 |
Geron Corporation |
Cns-tumor treatment method and composition
|
|
AU2008225100A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Mayo Foundation For Medical Education And Research |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
US9707274B2
(en)
|
2007-06-08 |
2017-07-18 |
Healthpartners Research & Education |
Methods for preventing and treating post-traumatic stress disorder (PTSD)
|
|
US8828960B2
(en)
*
|
2007-07-17 |
2014-09-09 |
Idexx Laboratories, Inc. |
Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
|
|
US9453204B2
(en)
*
|
2008-07-14 |
2016-09-27 |
Oklahoma Medical Research Foundation |
Production of pluripotent cells through inhibition of bright/ARID3a function
|
|
EP2862929B1
(en)
|
2009-12-09 |
2017-09-06 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treating diseases, disorders or injury of the CNS
|
|
EP2640461B1
(en)
|
2010-11-16 |
2019-06-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems for treatment of dry eye
|
|
US9821159B2
(en)
|
2010-11-16 |
2017-11-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Stimulation devices and methods
|
|
US8609088B2
(en)
|
2011-05-10 |
2013-12-17 |
Regents Of The University Of Minnesota |
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
|
|
WO2012174481A1
(en)
|
2011-06-15 |
2012-12-20 |
Nerve Access, Inc. |
Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders
|
|
EP3628325A1
(en)
*
|
2011-07-22 |
2020-04-01 |
The University of Chicago |
Treatments for migraine and related disorders
|
|
EP2822600A4
(en)
*
|
2012-03-09 |
2016-04-06 |
Univ Northeastern |
METHOD OF DISTRIBUTING NUCLEIC ACID ANOPARTICLES TO THE CENTRAL NERVOUS SYSTEM FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
|
|
US10279012B2
(en)
|
2013-03-11 |
2019-05-07 |
Healthpartners Research & Education |
Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin
|
|
EP2967817B1
(en)
|
2013-03-12 |
2021-03-10 |
Oculeve, Inc. |
Implant delivery devices and systems
|
|
HK1220934A1
(zh)
|
2013-04-19 |
2017-05-19 |
Oculeve, Inc. |
鼻刺激装置和方法
|
|
HK1222093A1
(zh)
|
2013-05-15 |
2017-06-23 |
明尼苏达大学董事会 |
腺相关病毒介导的基因向中枢神经系统转移
|
|
EP3110405B1
(en)
|
2014-02-25 |
2020-05-06 |
Oculeve, Inc. |
Polymer formulations for nasolacrimal stimulation
|
|
US10314911B2
(en)
|
2014-04-08 |
2019-06-11 |
Healthpartners Research & Education |
Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin
|
|
EP3673952A1
(en)
|
2014-07-25 |
2020-07-01 |
Oculeve, Inc. |
Stimulation patterns for treating dry eye
|
|
WO2016065213A1
(en)
|
2014-10-22 |
2016-04-28 |
Oculeve, Inc. |
Implantable nasal stimulator systems and methods
|
|
AU2015335772B2
(en)
|
2014-10-22 |
2020-07-09 |
Oculeve, Inc. |
Contact lens for increasing tear production
|
|
WO2016065215A1
(en)
|
2014-10-22 |
2016-04-28 |
Oculeve, Inc. |
Stimulation devices and methods for treating dry eye
|
|
SG11201705591PA
(en)
|
2015-01-07 |
2017-08-30 |
Trigemina Inc |
Magnesium-containing oxytocin formulations and methods of use
|
|
US10335435B2
(en)
|
2015-05-22 |
2019-07-02 |
Marco Merida |
Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach
|
|
US10426958B2
(en)
|
2015-12-04 |
2019-10-01 |
Oculeve, Inc. |
Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
|
|
US10252048B2
(en)
|
2016-02-19 |
2019-04-09 |
Oculeve, Inc. |
Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
|
|
HRP20250215T1
(hr)
|
2016-04-12 |
2025-06-20 |
Tonix Pharma Limited |
Formulacije oksitocina koje sadrže magnezij i postupci upotrebe
|
|
SG11201808176TA
(en)
|
2016-04-15 |
2018-10-30 |
The Trustees Of The Univ Of Pennsyvania |
Gene therapy for treating mucopolysaccharidosis type ii
|
|
AU2017260237A1
(en)
|
2016-05-02 |
2018-11-22 |
Oculeve, Inc. |
Intranasal stimulation for treatment of meibomian gland disease and blepharitis
|
|
US10610095B2
(en)
|
2016-12-02 |
2020-04-07 |
Oculeve, Inc. |
Apparatus and method for dry eye forecast and treatment recommendation
|
|
CN109498832B
(zh)
*
|
2017-09-15 |
2021-10-08 |
中国药科大学 |
一种交联多孔止血微球及其制备方法
|
|
CA3076036A1
(en)
|
2017-09-22 |
2019-03-28 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating mucopolysaccharidosis type ii
|
|
JP2022547948A
(ja)
|
2019-09-09 |
2022-11-16 |
ザ・ユニバーシティ・オブ・シカゴ |
片頭痛の処置のための併用療法
|
|
EP4045031A4
(en)
*
|
2019-10-16 |
2023-11-29 |
Brown University |
Muscle regeneration and growth
|
|
JP2023181674A
(ja)
*
|
2022-06-13 |
2023-12-25 |
国立大学法人 東京大学 |
核酸とカチオン性ポリマーとのポリイオンコンプレックスであって、正の表面電位を有し、核酸を脳組織に送達することができるポリイオンコンプレックス
|